Boston, MA -- (SBWIRE) -- 01/17/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Frontier Communications Corp (NASDAQ:FTR), Marvell Technology Group Ltd. (NASDAQ:MRVL), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Amarin Corporation plc (ADR) (NASDAQ:AMRN).
Frontier Communications Corp (NASDAQ:FTR), opened its shares at the price of $4.81for the day. Its closing price was $4.88 after gaining 2.42% for the day. The company traded with the total volume of 11.25 million shares, while its average trading volume remained 9.84 million shares. Frontier Communications Corporation, a communications company, provides regulated and unregulated voice, data, and video services to business, residential, and wholesale customers in the United States.
Will FTR Continue To Move Higher? Find Out Here
Marvell Technology Group Ltd. (NASDAQ:MRVL), percentage change plunged -4.90% to close at $14.76 with the total traded volume of 11.26 million shares, and average volume of 6.56 million. The 52 week range of the stock remained $8.50 - $15.82. Marvell Technology Group Ltd. designs, develops, and markets analog, mixed-signal, digital signal processing, and embedded and standalone ARM-based microprocessor integrated circuits
Will MRVL Get Buyers Even After The Recent Rally? Find Out Here
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), started its trading session with the price of $6.67 and closed at $6.74 by scoring 1.81%. ARIA’s stocks traded with total volume of 11.16 million shares, while the average trading volume remained 29.29 million sharesARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients.
Will ARIA Continue To Move Higher? Find Out Here
Amarin Corporation plc (ADR) (NASDAQ:AMRN) ended its day with the loss of -5.83% and closed at the price of $2.26 after opening at $2.21. Stock traded during its last trading session with the total volume of 10.55 million shares, as compared to its average volume of 7.05 million shares. Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids.
Will AMRN Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)